Literature DB >> 19892247

The pathophysiology of septic shock.

O Okorie Nduka1, Joseph E Parrillo.   

Abstract

There is a profound cellular dysfunction in sepsis, that clinically manifests as a continuum from simple, uncomplicated sepsis to severe sepsis, and finally to septic shock. Septic shock remains a significant challenge for clinicians. Recent advances in cellular and molecular biology have significantly improved our understanding of its pathogenetic mechanisms. These improvements will translate to better care and improved outcomes for these patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892247     DOI: 10.1016/j.ccc.2009.08.002

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  25 in total

Review 1.  Complexity science to conceptualize health and disease: is it relevant to clinical medicine?

Authors:  Saroj Jayasinghe
Journal:  Mayo Clin Proc       Date:  2012-04       Impact factor: 7.616

2.  MicroRNA-181b regulates NF-κB-mediated vascular inflammation.

Authors:  Xinghui Sun; Basak Icli; Akm Khyrul Wara; Nathan Belkin; Shaolin He; Lester Kobzik; Gary M Hunninghake; Miguel Pinilla Vera; Timothy S Blackwell; Rebecca M Baron; Mark W Feinberg
Journal:  J Clin Invest       Date:  2012-05-24       Impact factor: 14.808

3.  Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study.

Authors:  E Cadirci; Z Halici; F Odabasoglu; A Albayrak; E Karakus; D Unal; F Atalay; I Ferah; B Unal
Journal:  Clin Exp Immunol       Date:  2011-12       Impact factor: 4.330

4.  Lack of "immunological fitness" during fasting in metabolically challenged animals.

Authors:  Ingrid Wernstedt Asterholm; John McDonald; Pierre-Gilles Blanchard; Madhur Sinha; Qiang Xiao; Jehangir Mistry; Joseph M Rutkowski; Yves Deshaies; Rolf A Brekken; Philipp E Scherer
Journal:  J Lipid Res       Date:  2012-04-13       Impact factor: 5.922

5.  LPS pretreatment ameliorates multiple organ injuries and improves survival in a murine model of polymicrobial sepsis.

Authors:  Dong-Wei Shi; Jing Zhang; Hong-Ni Jiang; Chao-Yang Tong; Guo-Rong Gu; Yuan Ji; Hanssa Summah; Jie-Ming Qu
Journal:  Inflamm Res       Date:  2011-05-10       Impact factor: 4.575

6.  Sepsis: Something old, something new, and a systems view.

Authors:  Rami Namas; Ruben Zamora; Rajaie Namas; Gary An; John Doyle; Thomas E Dick; Frank J Jacono; Ioannis P Androulakis; Gary F Nieman; Steve Chang; Timothy R Billiar; John A Kellum; Derek C Angus; Yoram Vodovotz
Journal:  J Crit Care       Date:  2011-07-27       Impact factor: 3.425

7.  Role of Caveolin Proteins in Sepsis.

Authors:  Grzegorz Sowa
Journal:  Pediatr Ther       Date:  2012-01-12

8.  Lovastatin protects against experimental plague in mice.

Authors:  Saravanan Ayyadurai; Hubert Lepidi; Claude Nappez; Didier Raoult; Michel Drancourt
Journal:  PLoS One       Date:  2010-06-02       Impact factor: 3.240

Review 9.  Strategies to improve drug development for sepsis.

Authors:  Mitchell P Fink; H Shaw Warren
Journal:  Nat Rev Drug Discov       Date:  2014-09-05       Impact factor: 84.694

Review 10.  Role of miR-181 family in regulating vascular inflammation and immunity.

Authors:  Xinghui Sun; Alan Sit; Mark W Feinberg
Journal:  Trends Cardiovasc Med       Date:  2013-11-01       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.